[1]
2021. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches. Biomolecules and Biomedicine. 21, 3 (Jun. 2021), 270–283. DOI:https://doi.org/10.17305/bjbms.2020.5016.